
产品介绍 评论(0)
物种
Mouse抗原名称
BTNL2分子别名
BTL-II; Butyrophilin like 2; butyrophilin-like 2 (MHC class II associated); Butyrophilin-like 2Accession
O70355表达序列
Lys24-Trp454, with C-terminal Mouse mIgG2a Fc表达宿主
HEK293分子量
72-95kDa (Reducing)
纯度
>95% by SDS-PAGE内毒素含量
<0.1EU/μg标记
Unconjugated标签
Mouse Fc Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
1.Arnett, H.A. et al. (2007) J. Immunol. 178:1523.
2.Arnett, H.A. et al. (2009) Cytokine 46:370.
3.Smith, I.A. et al. (2010) J. Immunol. 184:3514.
4.Nguyen, T. et al. (2006) J. Immunol. 176:7354.
Butyrophilin-like 2 (BTNL2) is a member of the BTN/MOG Ig-superfamily and functions as a negative regulator of immune cell activation.BTNL2 is expressed in epithelial cells of the small intestine, colonic dendritic cells, and in cells of the lymph node. BTNL2 expression is upregulated in T cells following activation, a characteristic BTNL2 shares with the homologous B7 family of co-stimulatory molecules. BTNL2 negatively regulates T cells by inhibiting proliferation and inflammatory cytokine secretion. It also increases the expression of FoxP3 in T cells to promote regulatory T cell development. Single nucleotide polymorphisms in BTNL2 are associated with a risk for sporadic prostate cancer, rheumatoid arthritis, sarcoidosis, ulcerative colitis, and other inflammatory diseases.
电泳
- 1μg (R: reducing condition, N: non-reducing condition).







评论(0)